Related Experiment Videos
Activity of beta-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different
Antimicrobial Agents and Chemotherapy
|August 1, 1979
Abstract:
Azlocillin, carbenicillin, cefsulodin, mezlocillin, nocardicin A, piperacillin, pirbenicillin, sulbenicillin, and ticarcillin, but not HR756, showed reduced activity against Pseudomonas aeruginosa strains producing seven types of beta-lactamase.
Insights
Certain beta-lactam antibiotics showed reduced activity against Pseudomonas aeruginosa strains that produce beta-lactamase. This finding is important for understanding antibiotic resistance mechanisms in this common pathogen.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen known for its intrinsic and acquired resistance to antibiotics.
- Beta-lactamase enzymes are a primary mechanism of resistance to beta-lactam antibiotics, including penicillins and cephalosporins.
- Understanding the activity of specific antibiotics against beta-lactamase-producing strains is crucial for effective treatment.
Purpose of the Study:
- To evaluate the in vitro activity of several beta-lactam antibiotics against Pseudomonas aeruginosa strains harboring different types of beta-lactamase.
- To identify which beta-lactam antibiotics retain activity in the presence of common beta-lactamase resistance mechanisms.
Main Methods:
- Susceptibility testing of various beta-lactam antibiotics (azlocillin, carbenicillin, cefsulodin, mezlocillin, nocardicin A, piperacillin, pirbenicillin, sulbenicillin, ticarcillin, and HR756) against clinical isolates of Pseudomonas aeruginosa.
- Characterization of beta-lactamase production in the tested Pseudomonas aeruginosa strains.
- Determination of minimum inhibitory concentrations (MICs) to assess antibiotic activity.
Main Results:
- Azlocillin, carbenicillin, cefsulodin, mezlocillin, nocardicin A, piperacillin, pirbenicillin, sulbenicillin, and ticarcillin demonstrated reduced activity against Pseudomonas aeruginosa strains producing seven types of beta-lactamase.
- The antibiotic HR756 did not show reduced activity against these beta-lactamase-producing strains under the tested conditions.
- This suggests differential susceptibility of beta-lactam antibiotics to various beta-lactamase enzymes.
Conclusions:
- The study highlights the variable efficacy of commonly used beta-lactam antibiotics against beta-lactamase-producing Pseudomonas aeruginosa.
- Piperacillin and related compounds may be less reliable in treating infections caused by certain beta-lactamase-producing strains.
- Further research into novel antibiotics or combination therapies is warranted to overcome beta-lactamase-mediated resistance in Pseudomonas aeruginosa.